Sort
48,018 grants matching “immunotherapy”
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$586,358Alejandro V Villagra · George Washington University · R01 · FY2021 · CA
Program Leaders
$586,335Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2016 · CA
Engineering immunotherapeutic probiotics to mitigate irAE
$586,329Tal Danino · Columbia Univ New York Morningside · U01 · FY2020 · CA
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients
$586,159Annette M Molinaro · University Of California, San Francisco · P50 · FY2023 · CA
Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
$586,155James M Markert · University Of Alabama At Birmingham · R01 · FY2018 · CA
Mechanisms of immune-epithelial crosstalk in tissue repair
$586,123Shruti Naik · New York University School Of Medicine · R01 · FY2022 · AI
Naive T cell depletion to prevent graft-versus-host disease
$586,112Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL
UCSF Project 1
$585,896Trever G Bivona · University Of California, San Francisco · U54 · FY2019 · CA
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs
$585,879James Burton Whitney · Beth Israel Deaconess Medical Center · R01 · FY2016 · AI
Preclinical development and clinical monitoring of adoptive immune therapy
$585,861Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
"Off-the-Shelf" iPSC-Derived Regulatory T Cell Immunotherapeutics
$585,829Bruce R. Blazar · University Of Minnesota · P01 · FY2025 · CA
Lab Research Training in Pediatric Oncology-Hematology
$585,732Alan D Friedman · Johns Hopkins University · T32 · FY2023 · CA
Genetic dissection of defensin signaling in urinary tract infections
$585,731Xintong Dong · University Of Texas Dallas · R01 · FY2025 · DK
Immunobiology and immunotherapy of pancreatic cancer
$585,722Robert H Vonderheide · University Of Pennsylvania · R01 · FY2013 · CA
Reprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral Cancer
$585,606J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · DE
Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD
$585,577Jonathan Kipnis · Washington University · R01 · FY2022 · AG
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance
$585,570Stephen H Safe · Texas A&M University · R01 · FY2023 · CA
Viscoelasticity and T Cell Production
$585,468David J Mooney · Harvard University · R01 · FY2024 · CA
Novel Transgenic Mouse Models Addressing Outstanding Translational Barriers in Antibody-Based Therapeutics
$585,459Stylianos Bournazos · Rockefeller University · R01 · FY2024 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$585,447Warren S Pear · University Of Pennsylvania · T32 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$585,317Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2025 · CA
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
$585,212Baohua Zhou · Indiana University Indianapolis · R01 · FY2025 · CA
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
$585,212Baohua Zhou · Indiana University Indianapolis · R01 · FY2023 · CA
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
$585,209Jing Hong Wang · University Of Colorado Denver · R01 · FY2018 · DE
ChAT, AChE, and Cholinergic Neurons in Aging and AD
$585,182Steven G Younkin · Mayo Clinic Jacksonville · R01 · FY2010 · AG